周一，Wave Life Sciences (WVE.US)开盘飙升近80%，创年内新高，报13.42美元。消息面上，该公司表示，其用于治疗肥胖症的WVE-007一期试验的中期数据显示，身体成分有所改善，在最低治疗剂量下，体重减轻效果与GLP-1类似，但没有肌肉损失。

The Chinese Academy of Sciences (CAS), by far China's largest research organization, led the ranking, with Zhejiang ...

智通财经APP获悉，继周一飙升147%后，周二Wave Life Sciences(WVE.US)盘前续涨近10%，报20.28美元。消息面上，12月8日，Wave Life Sciences公布了其肥胖症候选药物WVE-007的I期INLIGHT试验中期数据，该数据来自32名接受单次240mg皮下注射的受试者，显示12周后内脏脂肪减少9.4%，全身脂肪下降4.5%，瘦体重增加3.2%。WVE-0 ...

We may not have a time machine yet, but it is time to sit back and re-experience 2025. AZoQuantum’s Year in Review rounds up ...

PALO ALTO - Kodiak Sciences Inc. (NASDAQ:KOD) 周一宣布已开始承销公开发行600万股普通股，并计划授予承销商30天期权，可额外购买最多90万股。此公告发布之际，该公司股票在过去六个月内经历了惊人的513%涨幅，尽管最近一周回调了8.91%。

PALO ALTO - 专注于视网膜前商业化的生物技术公司 Kodiak Sciences Inc. (NASDAQ:KOD) 周二宣布，已为其扩大的公开发行定价，将以每股23.00美元的价格发行6,956,522股普通股。

Anthropic is launching Claude for Life Sciences, a new model aimed at aiding scientific research. Through integrations with leading life sciences players, the platform will help researchers at every ...

过去，新材料的研发动辄耗时十年、花费上亿。如今，AI+自动化实验平台的结合，让“材料发现”从一门艺术逐渐变成可规模化、可复制的工程。这不仅是效率的飞跃，更是科研范式的革命。

An ad hoc committee conducted a study examining the policy and programmatic steps that the nation can undertake to ensure the successful launch and sustainment of careers among the next generation of ...

Partnerships with giants like Eli Lilly and Thermo Fisher Scientific put biotech in the spotlight again, though founders still struggle to find investments in their hometown.